Insiders · GPCR

Xichen Lin

Chief Scientific Officer at Structure Therapeutics Inc. (GPCR)

Xichen Lin has filed 13 insider reports with the SEC since March 2024, as chief Scientific Officer at Structure Therapeutics Inc. (GPCR). The latest filing, on September 3, 2026, reports conversion of a derivative, exercise or conversion of a derivative and open-market sale at Structure Therapeutics Inc. (GPCR).

Filings
13
Companies
1
Bought on market
None
Sold on market
None

Companies where Xichen Lin is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Structure Therapeutics Inc. logo
GPCR
Structure Therapeutics Inc.
Chief Scientific Officer228,960$18.17Sep 3, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Xichen Lin with

Other insiders at the same companies

Questions about Xichen Lin

What is Xichen Lin's role at Structure Therapeutics Inc.?
Xichen Lin reports to the SEC as chief Scientific Officer at Structure Therapeutics Inc. (GPCR), according to the latest filing on September 3, 2026.
How many shares does Xichen Lin own?
After the latest filing that states it, Xichen Lin directly owned 228,960 shares of Structure Therapeutics Inc. (GPCR). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Xichen Lin bought or sold stock recently?
No open-market purchases or sales by Xichen Lin are on file. The filings report conversion of a derivative, exercise or conversion of a derivative, open-market sale and grant or award.
How do I get alerts when Xichen Lin files?
Follow Xichen Lin on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Xichen Lin filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Xichen Lin (SEC CIK 0001962926). Totals count each trade once, skipping amendments whose original is on file, from Mar 19, 2024 on. View on SEC EDGAR